FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3033258527> ?p ?o ?g. }

• W3033258527 endingPage "3442" @default.
• W3033258527 startingPage "3431" @default.
• W3033258527 abstract "Although current treatment strategies including systemic chemotherapy, local radiotherapy, biological immunology, and surgical resection have improved the remission rate of non-Hodgkin’s lymphoma (NHL) patients, the recurrence rate of the disease remains high, and the remission rate of retreatment after recurrence is low. Exploring and discovering new strategies for treating NHL has become a critical problem to be solved. Harmine (HM) has demonstrated anti-tumor activity; however, like most traditional Chinese medicines, it does not exhibit targeting behavior and is characterized by poor pharmacokinetics, which limits its clinical application. To solve these problems, we constructed a new anti-lymphoma drug delivery system using mesoporous silica nanoparticles (MSNs) loaded with HM. This complex passively targets the tumor tissue, shows pH-responsive drug release, is non-toxic, and has efficient anti-lymphoma properties. Compared with free HM, the tumor inhibition rates of the HM@MSNs was 72.36 ± 5.16% and inhibition of the formation of lymphoma cell clones. Likewise, HM@MSNs could up-regulate the apoptosis rate of Daudi cells to 23.61 ± 0.88%. Moreover, it can inhibit the activation of NF-κB and production of inflammatory cytokines TNF-α (20.9 ± 1.8%) and IL-6 (22.7 ± 2.1%). In nude mice transplanted tumor model treated with HM@MSNs, TUNEL exhibited diffuse red fluorescence in vivo, suggesting that HM@MSNs could significantly induce tumor tissue apoptosis, and HM@MSNs-treated tumor tissue significantly decreased the fluorescence signals of NF-κB p65, TNF-α and IL-6, indicating that it down-regulated the expression of the mentioned three factors, and HM@MSNs significantly inhibited the proliferation of tumor volume. The mentioned results suggested that HM@MSNs finally induced apoptosis of lymphoma cells via anti-inflammatory mechanism. In general, MSNs loaded with HM can be potentially applied to the treatment of NHL." @default.
• W3033258527 created "2020-06-12" @default.
• W3033258527 creator A5008932652 @default.
• W3033258527 creator A5010630605 @default.
• W3033258527 creator A5011982092 @default.
• W3033258527 creator A5035163413 @default.
• W3033258527 creator A5035519834 @default.
• W3033258527 creator A5043738210 @default.
• W3033258527 creator A5052293051 @default.
• W3033258527 creator A5052883326 @default.
• W3033258527 creator A5079289428 @default.
• W3033258527 date "2020-06-04" @default.
• W3033258527 modified "2023-09-26" @default.
• W3033258527 title "Development of a nano-drug delivery system based on mesoporous silica and its anti-lymphoma activity" @default.
• W3033258527 cites W1029838470 @default.
• W3033258527 cites W1533021978 @default.
• W3033258527 cites W1983888890 @default.
• W3033258527 cites W1986579589 @default.
• W3033258527 cites W1993390114 @default.
• W3033258527 cites W1997565504 @default.
• W3033258527 cites W2006049488 @default.
• W3033258527 cites W2007456673 @default.
• W3033258527 cites W2007828305 @default.
• W3033258527 cites W2035135710 @default.
• W3033258527 cites W2054383588 @default.
• W3033258527 cites W2063937222 @default.
• W3033258527 cites W2064610182 @default.
• W3033258527 cites W2071392290 @default.
• W3033258527 cites W2078757666 @default.
• W3033258527 cites W2097997523 @default.
• W3033258527 cites W2109763190 @default.
• W3033258527 cites W2118278569 @default.
• W3033258527 cites W2124399952 @default.
• W3033258527 cites W2127629565 @default.
• W3033258527 cites W2192524675 @default.
• W3033258527 cites W2331176038 @default.
• W3033258527 cites W2409057459 @default.
• W3033258527 cites W2554294021 @default.
• W3033258527 cites W2586360846 @default.
• W3033258527 cites W2613420286 @default.
• W3033258527 cites W2734464855 @default.
• W3033258527 cites W2772553845 @default.
• W3033258527 cites W2898671650 @default.
• W3033258527 cites W2905282976 @default.
• W3033258527 cites W2906764941 @default.
• W3033258527 cites W2925168986 @default.
• W3033258527 cites W2938190556 @default.
• W3033258527 cites W2945976402 @default.
• W3033258527 cites W2971643926 @default.
• W3033258527 cites W2980846394 @default.
• W3033258527 cites W2995669627 @default.
• W3033258527 cites W3019902125 @default.
• W3033258527 doi "https://doi.org/10.1007/s13204-020-01465-0" @default.
• W3033258527 hasPublicationYear "2020" @default.
• W3033258527 type Work @default.
• W3033258527 sameAs 3033258527 @default.
• W3033258527 citedByCount "5" @default.
• W3033258527 countsByYear W30332585272021 @default.
• W3033258527 countsByYear W30332585272022 @default.
• W3033258527 countsByYear W30332585272023 @default.
• W3033258527 crossrefType "journal-article" @default.
• W3033258527 hasAuthorship W3033258527A5008932652 @default.
• W3033258527 hasAuthorship W3033258527A5010630605 @default.
• W3033258527 hasAuthorship W3033258527A5011982092 @default.
• W3033258527 hasAuthorship W3033258527A5035163413 @default.
• W3033258527 hasAuthorship W3033258527A5035519834 @default.
• W3033258527 hasAuthorship W3033258527A5043738210 @default.
• W3033258527 hasAuthorship W3033258527A5052293051 @default.
• W3033258527 hasAuthorship W3033258527A5052883326 @default.
• W3033258527 hasAuthorship W3033258527A5079289428 @default.
• W3033258527 hasBestOaLocation W30332585271 @default.
• W3033258527 hasConcept C126322002 @default.
• W3033258527 hasConcept C150903083 @default.
• W3033258527 hasConcept C161790260 @default.
• W3033258527 hasConcept C178790620 @default.
• W3033258527 hasConcept C185592680 @default.
• W3033258527 hasConcept C190283241 @default.
• W3033258527 hasConcept C196795494 @default.
• W3033258527 hasConcept C203014093 @default.
• W3033258527 hasConcept C207001950 @default.
• W3033258527 hasConcept C2776694085 @default.
• W3033258527 hasConcept C2777496208 @default.
• W3033258527 hasConcept C2779338263 @default.
• W3033258527 hasConcept C2779820397 @default.
• W3033258527 hasConcept C502942594 @default.
• W3033258527 hasConcept C55493867 @default.
• W3033258527 hasConcept C71924100 @default.
• W3033258527 hasConcept C82776694 @default.
• W3033258527 hasConcept C86803240 @default.
• W3033258527 hasConcept C98274493 @default.
• W3033258527 hasConceptScore W3033258527C126322002 @default.
• W3033258527 hasConceptScore W3033258527C150903083 @default.
• W3033258527 hasConceptScore W3033258527C161790260 @default.
• W3033258527 hasConceptScore W3033258527C178790620 @default.
• W3033258527 hasConceptScore W3033258527C185592680 @default.
• W3033258527 hasConceptScore W3033258527C190283241 @default.
• W3033258527 hasConceptScore W3033258527C196795494 @default.
• W3033258527 hasConceptScore W3033258527C203014093 @default.

• next